The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool

NCT04811638 | Completed

• 1 other identifier: Saglik Bilimleri University
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity.

Conditions

ICU Patients; ICU Acquired Weakness

Keywords

Physical Function; Critical İll; ICU Acquired Weakness

Outcome Measures

Primary Outcomes (1)

• Chelsea Critical Care Physical Assesment Tools

  The Chelsea critical care physical assessment (CPAx) is a measurement tool used to assess physical function in the ICU. The Chelsea critical care physical assessment (CPAx) tool is an outcome measure designed to assess 10 domains of physical ability: respiratory function, cough, bed mobility, supine to sitting on the edge of the bed, dynamic sitting, sit to stand, standing balance, transferring from bed to chair, stepping and grip strength. The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability.

  three days

Secondary Outcomes (1)

• Physical Function in Intensive Care Test

  three days

Interventions

Validation of the Chelsea Critical Care Physical Assesment Tools OTHER

The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability. PFIT used for criterion validity.

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

ICU patients

You may qualify if:

• Older than 18 years
• Critical adult patients
• Patients who were hospitalized for more than 48 hours in an ICU

You may not qualify if:

• Unstable fracture
• Limb deformities and dysfunction
• Myasthenia gravis
• Neuromuscular dysfunction
• Patients who diagnosed COVİD-19

Sponsors & Collaborators

• Saglik Bilimleri Universitesi: lead
• Medical Park Hospital Istanbul: collaborator

Study Sites (1)

Mehmet Burak Uyaroğlu

Istanbul, 34415, Turkey (Türkiye)

Location

Study Officials

• Esra Pehlivan, Ass.Prof

  Saglik Bilimleri Universitesi

  STUDY DIRECTOR

• Mehmet Burak Uyaroğlu, PT, MSc

  Saglik Bilimleri Universitesi

  PRINCIPAL INVESTIGATOR

• Sümeyye Akcay, PT, MSc

  Saglik Bilimleri Universitesi

  STUDY CHAIR

• Gamze Koyutürk, PT, MSc

  Saglik Bilimleri Universitesi

  STUDY CHAIR

• Hakan Parlak, MD

  Istinye University Bahcesehir Hospital

  STUDY CHAIR

• Kürsat Baydilli, PhD

  Saglik Bilimleri Universitesi

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 8, 2021
• First Posted: March 23, 2021
• Study Start: January 11, 2021
• Primary Completion: January 11, 2021
• Study Completion: January 14, 2021
• Last Updated: August 23, 2023

Record last verified: 2023-08

Locations

TU (1)